We are live on !
Find out more
Commonwealth Equity Services Portfolio holdings
AUM
$79.5B
Turnover
11.02%
1-Year Est. Return
27.1%
This Fund
S&P 500
This Quarter Est. Return
+15.68%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.22%
AUM
$79.5B
AUM Growth
+$7.93B
(+11%)
Cap. Flow
-$643M
Cap. Flow % of AUM
Cap. Flow %
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
16.98%
Holding
4,611
New
312
Increased
1,846
Reduced
2,170
Closed
196
Avg Time Held
5.9
years
Top 10 Avg Time Held
8.7
years
Top 20 Avg Time Held
7.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$70M |
| 2 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$65.3M |
| 3 |
Fidelity Fundamental Large Cap Growth ETF
FFLG
|
+$50M |
| 4 |
Eli Lilly
LLY
|
+$42.5M |
| 5 |
SpaceX
SPCX
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$122M |
| 2 |
NVIDIA
NVDA
|
+$99.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.3M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$79.7M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$69.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.62% |
| 2 | Technology | 12.02% |
| 3 | Financials | 4.01% |
| 4 | Industrials | 3.47% |
| 5 | Consumer Discretionary | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
Takeda Pharmaceutical
TAK
$65B
| $362K | ﹤0.01% |
22,598
+2,564
| +13% | +$42.4K |
2019 Q1
29 quarters
|
|
3602
Brunswick
BC
$4.43B
| $362K | ﹤0.01% |
4,296
-246
| -5% | -$19.7K |
2021 Q2
20 quarters
|
|
3603
Xtrackers Europe Defense Technologies ETF
XDEF
$4.11M
| $362K | ﹤0.01% |
+17,311
| New | +$383K |
2026 Q2
0 quarters
|
|
3604
Origin Bancorp
OBK
$1.62B
| $362K | ﹤0.01% |
7,072
+115
| +2% | +$5.41K |
2022 Q4
14 quarters
|
|
3605
Cavco Industries
CVCO
$4.21B
| $360K | ﹤0.01% |
586
+13
| +2% | +$6.9K |
2024 Q4
6 quarters
|
|
3606
Invesco International BuyBack Achievers ETF
IPKW
$547M
| $360K | ﹤0.01% |
6,388
-1,116
| -15% | -$64.7K |
2024 Q3
7 quarters
|
|
3607
VanEck Robotics ETF
IBOT
$98.4M
| $360K | ﹤0.01% |
+5,232
| New | +$360K |
2026 Q2
0 quarters
|
|
3608
Schwab Fundamental International Small Company Index ETF
FNDC
$3.03B
| $360K | ﹤0.01% |
7,409
-17,662
| -70% | -$870K |
2018 Q2
32 quarters
|
|
3609
Voya Financial
VOYA
$8.92B
| $360K | ﹤0.01% |
3,972
-692
| -15% | -$56.4K |
2024 Q3
7 quarters
|
|
3610
Element Solutions
ESI
$8.07B
| $359K | ﹤0.01% |
7,526
+730
| +11% | +$30.3K |
2026 Q1
1 quarter
|
|
3611
Haemonetics
HAE
$5.28B
| $359K | ﹤0.01% |
4,789
-157
| -3% | -$10.1K |
2024 Q1
9 quarters
|
|
3612
First Trust Alternative Absolute Return Strategy ETF
FAAR
$247M
| $359K | ﹤0.01% |
11,345
-5,408
| -32% | -$181K |
2021 Q1
21 quarters
|
|
3613
Parametric Equity Premium Income ETF
PAPI
$526M
| $359K | ﹤0.01% |
13,431
-7,861
| -37% | -$210K |
2024 Q4
6 quarters
|
|
3614
Crocs
CROX
$5.8B
| $358K | ﹤0.01% |
2,971
-3,868
| -57% | -$423K |
2021 Q1
21 quarters
|
|
3615
EDAP TMS S.A.
FOCL
$196M
| $358K | ﹤0.01% |
69,160
| – | – |
2018 Q3
31 quarters
|
|
3616
iShares International Developed Small Cap Value Factor ETF
ISVL
$323M
| $358K | ﹤0.01% |
7,113
-642
| -8% | -$32.9K |
2025 Q1
5 quarters
|
|
3617
Roivant Sciences
ROIV
$27.1B
| $358K | ﹤0.01% |
10,117
-6,777
| -40% | -$200K |
2023 Q4
10 quarters
|
|
3618
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$503M
| $358K | ﹤0.01% |
58,280
-1,701
| -3% | -$10.3K |
2013 Q2
52 quarters
|
|
3619
10x Genomics
TXG
$9.09B
| $357K | ﹤0.01% |
+9,308
| New | +$244K |
2026 Q2
0 quarters
|
|
3620
iShares MSCI Mexico ETF
EWW
$1.48B
| $357K | ﹤0.01% |
4,737
+26
| +0.6% | +$2.02K |
2024 Q4
6 quarters
|
|
3621
Bath & Body Works
BBWI
$4.36B
| $356K | ﹤0.01% |
15,401
+1,044
| +7% | +$20K |
2025 Q4
2 quarters
|
|
3622
State Street SPDR S&P Health Care Services ETF
XHS
$216M
| $356K | ﹤0.01% |
2,693
| – | – |
2017 Q1
37 quarters
|
|
3623
Ares Commercial Real Estate
ACRE
$181M
| $356K | ﹤0.01% |
79,043
-2,652
| -3% | -$13.1K |
2023 Q1
13 quarters
|
|
3624
Levi Strauss
LEVI
$8.19B
| $356K | ﹤0.01% |
14,320
+125
| +0.9% | +$2.82K |
2020 Q2
24 quarters
|
|
3625
XPLR Infrastructure LP
XIFR
$928M
| $355K | ﹤0.01% |
30,092
-548
| -2% | -$6.12K |
2018 Q2
32 quarters
|
|
Similar funds
Commonwealth Equity Services's Q2 2026 Portfolio in Review
As of Q2 2026, Commonwealth Equity Services held 4,611 positions worth $79.5B, up 11% from $71.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Commonwealth Equity Services's Q2 2026 filing shows 312 new, 1,846 increased, 2,170 reduced and 196 closed positions. Its largest new stake was SpaceX: 238,120 shares worth $40.7M. The largest sale was Apple, an estimated $122M.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, up from 66% a quarter earlier, followed by Technology and Financials.
- Commonwealth Equity Services's largest Q2 2026 buy was SpaceX: 238,120 shares worth $40.7M.
- Commonwealth Equity Services added most to Invesco NASDAQ 100 ETF in Q2 2026, an estimated $70M increase.
- Commonwealth Equity Services's biggest Q2 2026 reduction was Apple, cutting an estimated $122M.
- Commonwealth Equity Services fully exited Convergence Long/Short Equity ETF in Q2 2026, selling an estimated $7.88M.
- Commonwealth Equity Services's ten largest holdings make up 17% of its $79.5B portfolio in Q2 2026.
- Commonwealth Equity Services opened 312 new positions and closed 196 in Q2 2026.
- Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $79.5B.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.